Ask The Recruiter

Iovance Biotherapeutics

Pay Change, last update 1 day ago

Pharma biotech · Headquarters United States

Everything we hold on Iovance Biotherapeutics, newest first. Every line links to the filing or report it came from.

3 updates tracked
1 leadership change
20 Mar 2026 tracked since
United States where

This profile is thin because we hold 2 source documents on Iovance Biotherapeutics so far, not because nothing else has happened there. We only publish what we have read on a primary source and can link to. So a profile fills up as filings and reports come in, and we never seed it from an estimate. We keep profiles at this stage out of our sitemap and mark them noindex until they carry enough to be worth a search result of their own.

  1. 2026-08-15
    Pay Change Pay and benefits

    Iovance Biotherapeutics advertises a median posted salary band of $145,000 to $160,000 across 19 open roles

    Advertised bands move before published pay data does, because they are set by what an employer thinks it must offer to fill a role today. Read the direction across postings rather than any one band, and remember this is the ask, not the settlement.

    United States · News Report · Greenhouse job board · No archive snapshot yet. We re-check weekly; next check by Aug 23.

  2. 2026-08-15
    Headcount Not Stated Ways of working

    Iovance Biotherapeutics advertises 100% of its open roles as fully remote

    What an employer advertises is the offer a candidate can accept today. It moves before any return-to-office announcement, because a policy reaches the job postings before it reaches a press release. Read it as the shape of the roles being hired for, not of the whole workforce, and read the direction rather than the exact share.

    United States · News Report · Greenhouse job board · No archive snapshot yet. We re-check weekly; next check by Aug 23.

  3. 2026-03-20
    Headcount Not Stated Leadership moves

    IOVANCE BIOTHERAPEUTICS, INC. 8-K filing (Item 5.02): officer or director change

    Wendy Yarno retires from Iovance Biotherapeutics' board in San Carlos, with no disagreement cited.

    United States · Official Filing · SEC EDGAR

The read-through on each line is our interpretation. The headline and figures come from the linked source. Data licensed CC BY 4.0. Back to the tracker